Survival analysis after pancreatic resection for ampullary and pancreatic head carcinoma: An analysis of clinicopathological factors

Journal of Surgical Oncology

Volumn 100, Issue 8, 2009, Pages 651-656

  Sommerville, C A M ^a   Limongelli, P ^a   Pai, M ^a   Ahmad, R ^a   Stamp, G ^a   Habib, N A ^a   Williamson, R C N ^a   Jiao, L R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Ampullary carcinomas; Pancreatic carcinomas; Survival differences

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORBIDITY; MULTIVARIATE ANALYSIS; PANCREAS CARCINOMA; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT DURATION; TUMOR VOLUME; VATER PAPILLA CARCINOMA;

ADULT; AGED; AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; HUMANS; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY;

EID: 73449106095     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21390     Document Type: Article

References (26)

1. Cameron JL, Riall TS, Coleman J, et al.: One thousand consecutive pancreaticoduodenectomies. Ann Surg 2006;244: 10-15.
2. Sarmiento J, Nagorney D, Sarr M, et al.: Periampullary cancers: Are there differences? Surg Clin North Am 2001;81:543-555.
3. Bouvet M, Gamagami R, Gilpin E, et al.: Factors influencing survival after resection for periampullary neoplasms. Am J Surg 2000;180:13-17.
4. Jarufe N, Coldham A, Mayer A, et al.: Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region. Dig Surg 2004;21:202-209.
5. van Geenen R, van Gulik T, Offerhaus GJ, et al.: Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: An update. Eur J Surg Oncol 2001;27:549-557.
6. Williamson R: The pancreas. In: Keen G, Farndon J, editors. Operative surgery and management. Oxford, England: Butterworth Heinemann; 1994. pp. 161-185.
7. Hermanek P, Sobin L: TNM classification of malignant tumours, 4th edition. Berlin, Germany: Springer; 1988.
8. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
9. Cox D: Regression models and life tables. J R Stat Soc 1972;34: 187-202.
10. Howe J, Klimstra D, Moccia R, et al.: Factors predictive of survival in ampullary carcinoma. Ann Surg 1998;228:87-94.
11. Howard T, Krug J, Jian YJ, et al.: A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 2006;10:1338-1346.
12. Winter J, Cameron J, Campbell K, et al.: 1423 Pancreaticoduodenectomies for pancreatic cancer: A single institution experience. J Gastrointest Surg 2006;10:1199-1211.
13. Morris-Stiff G, Tamijmarane A, Tan YM, et al.: Survival advantage in ampullary carcinoma: Tumour biology or lead-time bias due to tumour morphology? Eur J Surg Oncol 2006;32:S72-S73.
14. Brown K, Tomkins A, Yong S, et al.: Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary carcinoma. Arch Surg 2005;140:529-533.
15. Roder J, Schneider P, Stein H, et al.: Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg 1995;82:1693-1696.
16. Sakata J, Shirai Y, Wakai T, et al.: Number of positive lymph nodes independently affects long term survival after resection in patients with ampullary carcinoma [published online ahead of print November 9, 2006]. Eur J Surg Oncol 2007;33:346-351.
17. Stojadinovic A, Brooks A, Hoos A, et al.: An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg 2003;196:954-964.
18. Reddy SK, Tyler DS, Pappas TN, et al.: Extended resection for pancreatic adenocarcinoma. Oncologist 2007;12:654-663.
19. Riall TS, Cameron JL, Lillemoe KD, et al.: Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 3: Update on 5-year survival. J Gastroinest Surg 2005;9:1191-1204; discussion 1204-1206.
20. Kalser M, Ellenberg S: Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899-903.
21. Klinkenbijl J, Jeeke J, Sahmoud T, et al.: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999; 230:776-782.
22. Neoptolemos JP, Stocken DD, Friess H, et al.: European Study Group for pancreatic cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210.
23. Limongelli P, Pai M, Bansi D, et al.: Correlation between preoperative biliary drainage, bile duct contamination, and postoperative outcomes for pancreatic surgery. Surgery 2007; 142:313-318.
24. Vaidya P, Kawarada Y, Higashiguchi T, et al.: Overexpression of different members of the type I growth factor receptor family and their association with cell proliferation in periampullary carcinoma. J Pathol 1996;178:140-145.
25. McCarthy DM, Hruban RH, Argani P, et al.: Role of the DPC4 tumour suppressor gene in adenocarcinoma of the ampulla of Vater: Analysis of 140 cases. Mod Pathol 2003;16:272-278.
26. Takashima M, Ueki T, Nagai E, et al.: Carcinoma of the ampulla of Vater associated with or without adenoma: A clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions. Mod Pathol 2000;13:1300-1307.